Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 3.850
+0.010 (0.26%)
Sep 18, 2026, 4:08 PM HKT
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 1.76 billion as of September 18, 2026. Its market cap has decreased by -91.47% in one year.
Market Cap
1.76B
Enterprise Value
752.47M
Revenue
176.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.85
ChartMarket Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 1.76B, a decrease of -93.28%. That is a compound annual growth rate of -91.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.76B | -87.43% |
| Dec 31, 2025 | 14.00B | -46.48% |
| Aug 15, 2025 | 26.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.27B |
| Antengene Corporation | 2.25B |
| Frontage Holdings | 2.10B |
| AIM Vaccine | 1.98B |
| HighTide Therapeutics | 1.89B |
| Mabpharm | 1.61B |
| SinoMab BioScience | 1.56B |
| Shandong Boan Biotechnology | 1.52B |